(Q41711544)

7 October 2017

title

Timolol plus maximum tolerated antiglaucoma therapy: a one-year followup study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A462367

3 July 2022

3

M. A. Kass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A462367

3 July 2022

author name string

Ashburn FS Jr

1

1 reference

7 October 2017

F. S. Ashburn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A462367

3 July 2022

J. E. Gillespie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A462367

3 July 2022

B. Becker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A462367

3 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=462367

3 July 2022

publication date

1 May 1979

1 reference

7 October 2017

published in

Survey of Ophthalmology

1 reference

7 October 2017

volume

23

1 reference

7 October 2017

issue

6

1 reference

7 October 2017

page(s)

389-394

1 reference

10.1016/0039-6257(79)90233-9

7 October 2017

Identifiers

DOI

1 reference

7 October 2017

1 reference